Economics of Health Technology Assessment

On Tuesday 28th June 2016 OHE held a workshop on the topic of surrogate endpoints as predictors of overall survival in oncology. The workshop was commissioned by the Pharmaceutical Oncology Initiative (POI) as part of a wider research project being undertaken by OHE.

The Association of the British Pharmaceutical Industry, in conjunction with the Office of Health Economics, invites you to register for a webinar on Monday 18th July: New EQ-5D-5L value sets for England and the UK and implications for HTA.

“Complementary diagnostics” are defined as tests using biomarkers for risk assessment, diagnosis, prognosis, monitoring, and guiding therapeutic decisions. This White Paper presents a more comprehensive framework for considering their value contribution.

On Wednesday 18th May OHE’s Patricia Cubi-Molla presented an OHE Lunchtime Seminar on age, utilities and self-reported health. This post contains a short summary and the slides.

The inaugural PROMs Conference was held in Sheffield on Thursday 9th June 2016. This post contains presentations and posters given by the OHE team.

Paula Lorgelly has accepted an appointment as a Visiting Professor in the Division of Cancer Studies at King’s College London.

This is part two of two posts containing posters and presentations by members of the OHE team at ISPOR’s 21st Annual International Meeting held in Washington DC, 20-25th May 2016.

This is part one of two posts containing posters and presentations by members of the OHE team at ISPOR’s 21st Annual International Meeting held in Washington DC, 20-25th May 2016.

OHE’s Koonal Shah is co-author of a new paper examining EuroQol protocols for time trade-off valuation of health states.

This study provides an analytical framework, drawing on production function theory, to identify and quantify the determinants of relative effectiveness and sources of variation in the relative effectiveness of treatments between populations and healthcare systems.

Pages

Subscribe to RSS - Economics of Health Technology Assessment